China healthcare news, medical innovations & patient services
A practical eight-step guide to case review, hospital acceptance, China visa preparation, arrival, treatment and follow-up—with important eligibility and approval limits.
→ Read Full Article↗ Source: China MFA / NMPA / NHC / Chinamedtravel editorial team
Why proton therapy may reduce radiation to developing tissues in selected children with CNS tumors, what three hospital-reported cases show, and where the evidence still has limits.
→ Read Full Article↗ Source: Yangcheng Evening News reporting / NCI / peer-reviewed literature
A 2026 single-case report describes rechargeable DBS with local field potential sensing in Guangxi—while clarifying that automatic adaptive stimulation was not reported as active.
→ Read Full Article↗ Source: Neurosurgery Frontiers interview / Guangxi Daily / official hospital sources
Guangzhou Xinshi Hospital reports completing cell collection for the Greater Bay Area’s first gastric-cancer patient entering the satri-cel (CT041) CAR-T treatment pathway.
→ Read Full Article↗ Source: New Express / CARsgen Therapeutics / UNB
What LEQEMBI targets, who may be considered for treatment, how safety monitoring works, and how its profile differs from donanemab.
→ Read Full Article↗ Source: FDA / Eisai / Eli Lilly official prescribing information
CAR-T Beats Blood Cancers! Approved Medicines & Core Barriers, All in One Guide
→ Read Full Article↗ Source: ZUMA-1, ZUMA-7, ELIANA, TRANSCEND NHL 001, KarMMa and CARTITUDE-1
The world’s first solid-tumor CAR-T approved for gastric cancer. Targets, clinical data, eligible patients & limitations in one article
→ Read Full Article↗ Source: Nature Medicine / NCT03874897
From T cell biology and five generations of CAR design to haematological breakthroughs, autoimmune disease, solid tumours, allogeneic manufacturing and in vivo engineering.
→ Read Full Article↗ Source: Nature Reviews Immunology